secwatch.observer — SEC 8-K summary
======================================

Issuer:     Protara Therapeutics, Inc. (TARA)
CIK:        0001359931
Form:       8-K
Filed at:   2023-01-05T23:59:59+00:00
Accession:  0001213900-23-001140
Event type: other_material
Sentiment:  neutral
Materiality: 0.10
Item codes: 8.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Protara Therapeutics posts corporate presentation; content not detailed in filing
--------------------------------------------------------------------------------

- Presentation filed as Exhibit 99.1 and posted on IR page on January 5, 2023.
- Intended for use at investor meetings; no financial results or new pipeline data disclosed.
- No specific forward-looking statements or material events included in the filing text.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1359931/000121390023001140/0001213900-23-001140-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1359931/000121390023001140/ea171261-8k_protara.htm
  HTML page:      https://secwatch.observer/filing/0001213900-23-001140

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer